KATHERINE HAHNE: Open Payments
NPI 1598136905 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 26 payments from 19 companies in 2025. Trend: 2023 $747 · 2024 $1,228 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Celgene Corporation | 2 | $40 |
| Genmab U.S., Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Gilead Sciences, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| SOBI, INC | 1 | $27 |
| Eisai Inc. | 1 | $27 |
Products named: Enhertu, REBLOZYL, Tivdak, KISQALI, Trodelvy, Vonjo, Lenvima, Fyarro.
Industry payments across NC — which companies pay providers there.
